{"transactions":[{"id":677704,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-08-24T21:04:56.000Z","date":"2026-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":97627,"price":0.672,"value":65605.344,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024, March 21, 2025 and March 20, 2026, which grants were originally reported on Form 4s filed with the U.S. Securities and Exchange Commission on May 21, 2024, March 24, 2025 and April 8, 2026 respectively."}],"balance_after":6137704,"source":{"system":"sec-edgar","filing":"0001193125-26-363758","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526363758/ownership.xml","form_type":"4"}},{"id":697628,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-08-04T22:01:02.000Z","date":"2026-08-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":362625,"price":0.868,"value":314758.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on August 1, 2025, which grant was originally reported on a Form 4 filed with the U.S. Securities and Exchange Commission on August 5, 2025."}],"balance_after":6235331,"source":{"system":"sec-edgar","filing":"0001193125-26-333225","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526333225/ownership.xml","form_type":"4"}},{"id":766464,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-05-22T21:17:22.000Z","date":"2026-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":97626,"price":1,"value":97626.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024, March 21, 2025 and March 20, 2026, which grants were originally reported on Form 4s filed with the U.S. Securities and Exchange Commission on May 21, 2024, March 24, 2025 and April 8, 2026, respectively."}],"balance_after":6597956,"source":{"system":"sec-edgar","filing":"0001193125-26-237181","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526237181/ownership.xml","form_type":"4"}},{"id":812812,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2026-04-09T01:55:05.000Z","date":"2026-04-06","kind":"exercise","planned":false,"acquired":false,"shares":196513,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On April 4, 2022, the Reporting Person was granted 786,049 RSUs, vesting in four equal annual installments beginning on April 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On April 4, 2022, the Reporting Person was granted 786,049 RSUs, vesting in four equal annual installments beginning on April 4, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":196513},"source":{"system":"sec-edgar","filing":"0001193125-26-148615","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526148615/ownership.xml","form_type":"4"}},{"id":812811,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to buy)","published_at":"2026-04-09T01:55:05.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":2345340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Option becomes exercisable as to 1/16th of the underlying shares on May 20, 2026, with the remaining shares vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":2345340,"derivative":{"exercise_price":0.9846,"expiration_date":"2036-03-20","underlying":"Common Stock","underlying_shares":2345340},"source":{"system":"sec-edgar","filing":"0001193125-26-148615","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526148615/ownership.xml","form_type":"4"}},{"id":812810,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-04-09T01:55:05.000Z","date":"2026-04-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":95014,"price":0.908,"value":86272.712,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of RSUs granted to the reporting person on April 4, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on April 6, 2022."}],"balance_after":6695582,"source":{"system":"sec-edgar","filing":"0001193125-26-148615","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526148615/ownership.xml","form_type":"4"}},{"id":812809,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-04-09T01:55:05.000Z","date":"2026-04-06","kind":"exercise","planned":false,"acquired":true,"shares":196513,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6790596,"source":{"system":"sec-edgar","filing":"0001193125-26-148615","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526148615/ownership.xml","form_type":"4"}},{"id":812808,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-04-09T01:55:05.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":1042373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest over four years, with 1/16 of the RSUs vesting on May 20, 2026 and the remaining RSUs vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":6594083,"source":{"system":"sec-edgar","filing":"0001193125-26-148615","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526148615/ownership.xml","form_type":"4"}},{"id":885549,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-02-24T22:45:31.000Z","date":"2026-02-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":66127,"price":1.15,"value":76046.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024 and March 21, 2025, which grants were originally reported on Form 4s filed with the U.S. Securities and Exchange Commission on May 21, 2024 and March 24, 2025, respectively."}],"balance_after":5551710,"source":{"system":"sec-edgar","filing":"0001193125-26-067641","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526067641/ownership.xml","form_type":"4"}},{"id":990459,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-11-24T22:05:15.000Z","date":"2025-11-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":63529,"price":1.28,"value":81317.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024 and March 21, 2025, which grants were originally reported on Form 4s filed with the U.S. Securities and Exchange Commission on May 21, 2024 and March 24, 2025, respectively."}],"balance_after":5617837,"source":{"system":"sec-edgar","filing":"0001193125-25-293843","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312525293843/ownership.xml","form_type":"4"}},{"id":1058521,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-08-22T21:46:20.000Z","date":"2025-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":54919,"price":1.27,"value":69747.13,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024 and March 21, 2025, which grants were originally reported on Form 4s filed with the U.S. Securities and Exchange Commission on May 21, 2024 and March 24, 2025, respectively."}],"balance_after":5681366,"source":{"system":"sec-edgar","filing":"0000950170-25-111052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025111052/ownership.xml","form_type":"4"}},{"id":1075097,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-08-05T22:23:22.000Z","date":"2025-08-01","kind":"grant","planned":false,"acquired":true,"shares":3000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest as to 25% of the RSUs on August 1, 2026, with the remaining 75% of the RSUs vesting in three equal annual installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,000 shares  previously acquired by the Reporting Person under the Issuer's Employee Stock Purchase Plan."}],"balance_after":5736285,"source":{"system":"sec-edgar","filing":"0000950170-25-103296","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025103296/ownership.xml","form_type":"4"}},{"id":1129583,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-05-30T21:48:49.000Z","date":"2025-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":9906,"price":1.09,"value":10797.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 24, 2025."}],"balance_after":2731285,"source":{"system":"sec-edgar","filing":"0000950170-25-079886","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025079886/ownership.xml","form_type":"4"}},{"id":1132265,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-05-28T21:44:58.000Z","date":"2025-05-23","kind":"sale","planned":false,"acquired":false,"shares":5473,"price":0.941,"value":5150.093,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission (\"SEC\") on March 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $0.92 to $0.9748 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer."}],"balance_after":2741191,"source":{"system":"sec-edgar","filing":"0000950170-25-078457","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025078457/ownership.xml","form_type":"4"}},{"id":1133784,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-05-28T00:28:33.000Z","date":"2025-05-22","kind":"sale","planned":false,"acquired":false,"shares":5116,"price":1.002,"value":5126.232,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission (\"SEC\") on March 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $0.9403 to $1.03 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer."}],"balance_after":2746664,"source":{"system":"sec-edgar","filing":"0000950170-25-078043","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025078043/ownership.xml","form_type":"4"}},{"id":1137672,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-05-23T00:03:58.000Z","date":"2025-05-21","kind":"sale","planned":false,"acquired":false,"shares":4719,"price":1.03,"value":4860.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The shares were sold to satisfy the tax withholding obligations that arose upon the vesting of RSUs granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the SEC on March 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $1.015 to $1.05 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer."}],"balance_after":2751780,"source":{"system":"sec-edgar","filing":"0000950170-25-076591","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025076591/ownership.xml","form_type":"4"}},{"id":1137671,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-05-23T00:03:58.000Z","date":"2025-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":18343,"price":1.05,"value":19260.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units (\"RSUs\") granted to the reporting person on May 20, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission (\"SEC\") on May 21, 2024."}],"balance_after":2756499,"source":{"system":"sec-edgar","filing":"0000950170-25-076591","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025076591/ownership.xml","form_type":"4"}},{"id":1175841,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2025-04-08T20:04:11.000Z","date":"2025-04-04","kind":"exercise","planned":false,"acquired":false,"shares":196512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents the contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On April 4, 2022, the Reporting Person was granted 786,049 RSUs, vesting in four equal annual installments beginning on April 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On April 4, 2022, the Reporting Person was granted 786,049 RSUs, vesting in four equal annual installments beginning on April 4, 2023."}],"balance_after":196513,"derivative":{"underlying":"Common Stock","underlying_shares":196512},"source":{"system":"sec-edgar","filing":"0000950170-25-052047","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025052047/ownership.xml","form_type":"4"}},{"id":1175840,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-04-08T20:04:11.000Z","date":"2025-04-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":57676,"price":1.07,"value":61713.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units (\"RSUs\") granted to the reporting person on April 4, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on April 6, 2022."}],"balance_after":2774842,"source":{"system":"sec-edgar","filing":"0000950170-25-052047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025052047/ownership.xml","form_type":"4"}},{"id":1175839,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-04-08T20:04:11.000Z","date":"2025-04-04","kind":"exercise","planned":false,"acquired":true,"shares":196512,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2832518,"source":{"system":"sec-edgar","filing":"0000950170-25-052047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025052047/ownership.xml","form_type":"4"}},{"id":1193825,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to buy)","published_at":"2025-03-24T22:31:57.000Z","date":"2025-03-21","kind":"grant","planned":false,"acquired":true,"shares":1782500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option becomes exercisable as to 1/16th of the underlying shares on May 20, 2025, with the remaining shares vesting in equally quarterly installments, thereafter, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":1782500,"derivative":{"exercise_price":1.21,"expiration_date":"2035-03-21","underlying":"Common Stock","underlying_shares":1782500},"source":{"system":"sec-edgar","filing":"0000950170-25-044008","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025044008/ownership.xml","form_type":"4"}},{"id":1193824,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-03-24T22:31:57.000Z","date":"2025-03-21","kind":"grant","planned":false,"acquired":true,"shares":1188333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest over four years, with 1/16 of the RSUs vesting on May 20, 2025 and the remaining RSUs vesting in equally quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":2636006,"source":{"system":"sec-edgar","filing":"0000950170-25-044008","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025044008/ownership.xml","form_type":"4"}},{"id":1250095,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-02-24T22:30:04.000Z","date":"2025-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":31031,"price":1.39,"value":43133.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 21, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,000 shares of common stock acquired by the reporting person on May 31, 2024 under the Issuer's Employee Stock Purchase Plan."}],"balance_after":1447673,"source":{"system":"sec-edgar","filing":"0000950170-25-025806","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025025806/ownership.xml","form_type":"4"}},{"id":1356119,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-11-22T01:55:41.000Z","date":"2024-11-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":28795,"price":1.51,"value":43480.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 21, 2024."}],"balance_after":1473704,"source":{"system":"sec-edgar","filing":"0000950170-24-129877","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024129877/ownership.xml","form_type":"4"}},{"id":1414265,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-09-05T21:59:09.000Z","date":"2024-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":29093,"price":1.91,"value":55567.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 21, 2024."}],"balance_after":1502499,"source":{"system":"sec-edgar","filing":"0000950170-24-104132","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024104132/ownership.xml","form_type":"4"}},{"id":1507437,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-21T21:37:39.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":2250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option becomes exercisable as to 1/16th of the underlying shares on August 20, 2024, with the remaining shares vesting in equal quarterly installments over four years thereafter, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":2250000,"derivative":{"exercise_price":2.58,"expiration_date":"2034-05-20","underlying":"Common Stock","underlying_shares":2250000},"source":{"system":"sec-edgar","filing":"0000950170-24-063097","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024063097/ownership.xml","form_type":"4"}},{"id":1507436,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-05-21T21:37:39.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest as to 1/16th of the RSUs on August 20, 2024, with the remaining RSUs vesting in equally quarterly installments over four years thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":1531592,"source":{"system":"sec-edgar","filing":"0000950170-24-063097","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024063097/ownership.xml","form_type":"4"}},{"id":1544726,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-04-09T23:11:29.000Z","date":"2024-04-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":102564,"price":2.71,"value":277948.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain performance-based restricted stock units (\"RSUs\") granted to the reporting person on April 11, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on April 5, 2024 upon the determination by the Board of Directors of the Issuer that certain of the performance-based conditions were met."}],"balance_after":531592,"source":{"system":"sec-edgar","filing":"0000950170-24-043103","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024043103/ownership.xml","form_type":"4"}},{"id":1546960,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2024-04-05T22:59:07.000Z","date":"2024-04-04","kind":"exercise","planned":false,"acquired":false,"shares":196512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents the contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On April 4, 2022, the Reporting Person was granted 786,049 RSUs, vesting in four equal annual installments beginning on April 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On April 4, 2022, the Reporting Person was granted 786,049 RSUs, vesting in four equal annual installments beginning on April 4, 2023."}],"balance_after":393025,"derivative":{"underlying":"Common Stock","underlying_shares":196512},"source":{"system":"sec-edgar","filing":"0000950170-24-042373","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024042373/ownership.xml","form_type":"4"}},{"id":1546959,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-04-05T22:59:07.000Z","date":"2024-04-05","kind":"grant","planned":false,"acquired":true,"shares":212126,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On April 11, 2023, the Reporting Person was granted a target amount of 231,579 performance-based restricted stock units (\"RSUs\") under the Issuer's 2011 Equity Incentive Plan, as amended.  Each RSU represent the right, upon achievement of certain pre-established performance criteria, to receive one share of the Issuer's common stock, subject to vesting conditions. On April 5, 2024, the Board of Directors of the Issuer determined that certain of the RSU performance-based conditions were met resulting in the vesting of 212,126 RSUs as of March 31, 2024."}],"balance_after":634156,"source":{"system":"sec-edgar","filing":"0000950170-24-042373","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024042373/ownership.xml","form_type":"4"}},{"id":1546958,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-04-05T22:59:07.000Z","date":"2024-04-04","kind":"exercise","planned":false,"acquired":true,"shares":196512,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":422030,"source":{"system":"sec-edgar","filing":"0000950170-24-042373","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024042373/ownership.xml","form_type":"4"}},{"id":1546957,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-04-05T22:59:07.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":9006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Received in exchange for 8,114 shares of common stock of SomaLogic, Inc. (\"SomaLogic\") pursuant to the Agreement and Plan of Merger, dated October 4, 2023, by and among Standard BioTools Inc. (the \"Issuer\"), Martis Merger Sub, Inc. and SomaLogic (the \"Merger\"). Per the terms of the Merger, each share of SomaLogic common stock was converted into the right to receive 1.11 shares of the Issuer's common stock at the effective time of the Merger."}],"balance_after":225518,"source":{"system":"sec-edgar","filing":"0000950170-24-042373","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024042373/ownership.xml","form_type":"4"}},{"id":1923955,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2023-04-06T23:02:50.000Z","date":"2023-04-04","kind":"exercise","planned":false,"acquired":false,"shares":196512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vest in four equal annual installments beginning April 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vest in four equal annual installments beginning April 4, 2023."}],"balance_after":589537,"derivative":{"underlying":"Common Stock","underlying_shares":196512},"source":{"system":"sec-edgar","filing":"0001162194-23-000019","document":"wf-form4_168082215819281.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219423000019/wf-form4_168082215819281.xml","form_type":"4"}},{"id":1923954,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-04-06T23:02:50.000Z","date":"2023-04-04","kind":"exercise","planned":false,"acquired":true,"shares":196512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 5,000 shares of Common Stock purchased pursuant to Fluidigm Corporation (currently Standard BioTools Inc.) 2017 Employee Stock Purchase Plan (\"ESPP\") for the purchase period of June 1, 2022 to November 30, 2022."}],"balance_after":206512,"source":{"system":"sec-edgar","filing":"0001162194-23-000019","document":"wf-form4_168082215819281.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219423000019/wf-form4_168082215819281.xml","form_type":"4"}},{"id":2224939,"issuer":{"id":115290,"kind":"organization","name":"IsoPlexis Corp","symbol":"ISO"},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-06-21T13:44:24.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":89047,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests in full on the earlier of (i) the first anniversary of the date of grant or (ii) the day prior to the date of the next annual shareholders meeting"}],"balance_after":89047,"derivative":{"exercise_price":2.1,"expiration_date":"2032-06-10","underlying":"Common Stock","underlying_shares":89047},"source":{"system":"sec-edgar","filing":"0001062993-22-015242","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559779/000106299322015242/form4.xml","form_type":"4"}},{"id":2302782,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-06T22:35:59.000Z","date":"2022-04-04","kind":"grant","acquired":true,"shares":4529773,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Option becomes exercisable as to 1/4th of the underlying shares on April 4, 2023, and as to an additional 1/48th of the total number of shares each month thereafter."}],"balance_after":4529773,"derivative":{"exercise_price":3.99,"expiration_date":"2032-04-04","underlying":"Common Stock","underlying_shares":4529773},"source":{"system":"sec-edgar","filing":"0001162194-22-000045","document":"wf-form4_164928454559915.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219422000045/wf-form4_164928454559915.xml","form_type":"4"}},{"id":2302781,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20481,"kind":"person","name":"Egholm Michael","position":1,"cik":"0001559779","reported_name":"Egholm Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2022-04-06T22:35:59.000Z","date":"2022-04-04","kind":"grant","acquired":true,"shares":786049,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units vest in four equal annual installments beginning April 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units vest in four equal annual installments beginning April 4, 2023."}],"balance_after":786049,"derivative":{"underlying":"Common Stock","underlying_shares":786049},"source":{"system":"sec-edgar","filing":"0001162194-22-000045","document":"wf-form4_164928454559915.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219422000045/wf-form4_164928454559915.xml","form_type":"4"}}]}